CTT Pharmaceutical (CTTH) CEO Buys 10,000 Shares

What Happened The company's CEO reported an open-market purchase of 10,000 shares of CTT Pharmaceutical Holdings, Inc. The filing lists a per-share price of $0.06 and a total acquisition value reported as $590. This is a purchase (P), which is generally viewed as a more informative signal than routine sales, though the dollar amount here is very small.

Key Details

• Transaction date shown on the Form 4: 2026-08-19; Period of report: 2026-08-17; Form filed: 2026-08-19.
• Price: $0.06 per share; Reported total value: $590.
• Transaction type: P = Purchase (open market or private purchase).
• Shares owned after the transaction: Not disclosed in the provided filing summary.
• Footnotes/plan indicators: None noted in the provided data.
• Timeliness: Form 4 was filed Aug 19, 2026; no late-filing flag was indicated in the supplied information.

Context Insider purchases can signal confidence, but this purchase is very small in dollar terms ($590), so it should be interpreted cautiously and not taken alone as a strong endorsement. For retail investors, consider this alongside other insider activity, company fundamentals, and market conditions before making investment decisions.